Your partner in computational drug design
Silicos-it is a Belgian consultancy company, founded in 2010 and specialised in computational drug design. We provide support in all aspects of modern computational drug design, including virtual screening, molecular dynamics applications, and state-of-the-art structure-activity machine learning models. In addition, we are also involved in writing open source software tools.
Since 2013, a strong relation with the University of Antwerp (UA) was established. Because of this, we can provide you with a complete set of solutions to all your questions related to computational drug design. This may include service work under the wings of the UA, submission and execution of a VLAIO project with the UA as academic partner, or some well-defined fee-for-service projects with Silicos-it as the commercial partner.
Do you like to find out more of what we can do for you? Then have a look at the research examples page on this website for ideas and opportunities. And the who are we page gives you insight into our history and where we are right now.
Do you think we can help you? We are open to many forms of collaboration. Therefore, do not hesitate to contact us to discuss your potential research ideas. Maybe it is the beginning of a mind-blowing research collaboration!
Our latest post
-
Ferroptosis inhibition enhances liver and lung graft function
Researchers at the KU Leuven and University of Antwerp contributed to a large international team studying ferroptosis inhibition as a therapeutic strategy against ischemia-reperfusion injury in transplantation and related conditions. Our contribution in this work, which was published in the prestigious journal Cell resulted in panel H of Figure 2 — a small but significant part of the study, however representing more than six months of umbrella sampling calculations performed on the European supercomputer LUMI.